LUMATE-AT 120
MRP: 418
Packaging: 120mg
Pack Type: injection
Composition:
Artesunate 120mg
Indication:
Provides quick control on the symptoms of Malaria
Description:
Artesunate 120mg is a fast-acting injectable antimalarial medication used for the treatment of severe and complicated malaria, particularly caused by Plasmodium falciparum, including drug-resistant strains. It is a water-soluble hemisuccinate derivative of artemisinin and is recommended by the World Health Organization (WHO) for emergency malaria treatment.
Artesunate rapidly kills malaria parasites in the blood and is typically administered intravenously (IV) or intramuscularly (IM) in hospital settings. It is crucial for saving lives in critical malaria cases, especially when oral treatment is not possible.
Tags:
- Rapidly reduces parasite count
- Effective against multidrug-resistant P. falciparum
- Suitable for critically ill patients unable to take oral meds
- Life-saving in cerebral and severe malaria
- Transitioned to ACT (Artemisinin-based Combination Therapy) after stabilization
Usage Information
Dosage
Initial Dose: 2.4 mg/kg body weight IV/IM at 0, 12, and 24 hours, then once daily Dose Equivalence: 120mg for adult patients weighing approximately 50kg Route: Intravenous (IV) or Intramuscular (IM) Treatment Duration: Typically 3 days, followed by oral ACT (e.g., Artemether-Lumefantrine) Preparation: Requires reconstitution with sodium bicarbonate and 5% dextrose or saline before use
Side Effects
Injection site pain, redness Temporary hemolysis (especially in delayed cases) Fever, chills (sometimes due to malaria itself) Dizziness, weakness Nausea, vomiting Rare: Neutropenia, elevated liver enzymes
Contraindications
Known hypersensitivity to artemisinin or artesunate Caution in patients with G6PD deficiency Avoid use as prophylaxis or in uncomplicated malaria cases Use with caution in patients with renal or hepatic impairment